| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/10/2003 | US20030130168 Reverse-turn mimetics and methods relating thereto |
| 07/10/2003 | US20030130165 Method for treating neurodegenerative disorders |
| 07/10/2003 | US20030129702 DNA encoding galanin GALR2 receptors and uses thereof |
| 07/10/2003 | US20030129294 Hydroquinone-substituted fatty acid for use in foods; lipase inhibitors; peroxisome proliferator activated receptors; antiaging agents |
| 07/10/2003 | US20030129244 Morphine sulfate microgranules, manufacturing process and pharmaceutical preparations |
| 07/10/2003 | US20030129237 Multiparticulate modified release composition |
| 07/10/2003 | US20030129234 Methods of making sustained release formulations of oxymorphone |
| 07/10/2003 | US20030129230 Sustained release formulations of oxymorphone |
| 07/10/2003 | US20030129186 Compositions and methods for modulating blood-brain barrier transport |
| 07/10/2003 | US20030129145 Aftersmoking; converting nicotine to cotinine; discharing in urine |
| 07/10/2003 | US20030129134 Method of monitoring neuroprotective treatment |
| 07/10/2003 | US20030129129 Prevention, therapy disease; forming tritiated water; calibration |
| 07/10/2003 | CA2471713A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 07/10/2003 | CA2471540A1 A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
| 07/10/2003 | CA2471531A1 Agents for treating mild cognitive impairment |
| 07/10/2003 | CA2471348A1 Quinazolinone derivative |
| 07/10/2003 | CA2471306A1 Secreted proteins |
| 07/10/2003 | CA2471297A1 Human netrin receptor and uses thereof |
| 07/10/2003 | CA2471236A1 Urea derivatives |
| 07/10/2003 | CA2471217A1 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
| 07/10/2003 | CA2471039A1 Method of systemically delivering ssris |
| 07/10/2003 | CA2470781A1 Cystine-knot fold protein |
| 07/10/2003 | CA2470666A1 Secreted protein |
| 07/10/2003 | CA2469967A1 Urea derivatives as vr1- antagonists |
| 07/10/2003 | CA2469690A1 Beta-amyloid binding factors and inhibitors thereof |
| 07/10/2003 | CA2467337A1 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors |
| 07/10/2003 | CA2458751A1 Compositions and methods for the treatement of immune related diseases |
| 07/10/2003 | CA2457801A1 Streptococcus thermophilus strain and use thereof |
| 07/09/2003 | EP1325932A2 Anti-vegf antibodies |
| 07/09/2003 | EP1325921A2 Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators |
| 07/09/2003 | EP1325917A1 Radiolabelled alkylamino-benzothiazole and -benzoxazole derivatives and their use as D4 ligands |
| 07/09/2003 | EP1325916A1 Piperazinyl-substituted phenyl pyrimidine derivatives useful in the treatment or prevention of disorders of the central nervous system |
| 07/09/2003 | EP1325912A1 2,2-diphenylbutanamide derivatives and medicines containing the same |
| 07/09/2003 | EP1325909A1 Tricyclic indole compounds having affinity for serotonin receptor |
| 07/09/2003 | EP1325903A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 07/09/2003 | EP1325747A2 Dietary supplement for neuropaths |
| 07/09/2003 | EP1325746A1 Controlled release oxycodone compositions |
| 07/09/2003 | EP1325745A1 Preventives and remedies for complications of diabetes |
| 07/09/2003 | EP1325742A1 Improved transdermal therapeutic system for the treatment of Parkinson's disease |
| 07/09/2003 | EP1325338A2 Diagnosis and treatment of alzheimer's disease |
| 07/09/2003 | EP1325335A2 Methods for diagnosing and treating huntington's disease |
| 07/09/2003 | EP1325324A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 07/09/2003 | EP1325130A2 Nogo receptor homologs |
| 07/09/2003 | EP1325128A2 Lipocalins |
| 07/09/2003 | EP1325122A2 Modulation of the transcription of pro-inflammatory gene products |
| 07/09/2003 | EP1325117A2 Lipid metabolism enzymes |
| 07/09/2003 | EP1325031A2 Use of anti-human integrin alpha d antibodies to treat spinal cord injury |
| 07/09/2003 | EP1325028A2 New inhibitors of iapp fibril formation and uses thereof |
| 07/09/2003 | EP1325014A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 07/09/2003 | EP1325010A1 Substituted 3.4-dihydro-pyrimido 1,2-a]pyrimidines and 3.4-dihydropyrazino 1,2-a]pyrimidines |
| 07/09/2003 | EP1325008A1 Piperazine derivatives |
| 07/09/2003 | EP1325007A2 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 07/09/2003 | EP1325006A2 Heterocyclic compounds as ligands of the gaba a? receptor |
| 07/09/2003 | EP1325005A1 1,2,5,10-tetrahydropyridazino 4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
| 07/09/2003 | EP1325004A1 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
| 07/09/2003 | EP1325003A1 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino 4,5-b]quinoline-1,10-dione and the use thereof for the treatment of pain |
| 07/09/2003 | EP1325002A1 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
| 07/09/2003 | EP1324998A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 07/09/2003 | EP1324995A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 07/09/2003 | EP1324994A2 Tricyclic compounds and uses thereof |
| 07/09/2003 | EP1324992A1 Cyclized benzamide neurokinin antagonists for use in therapy |
| 07/09/2003 | EP1324991A1 Compounds useful in the treatment of inflammatory diseases |
| 07/09/2003 | EP1324990A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 07/09/2003 | EP1324986A1 Nitrogen-containing compounds and their use as glycine transport inhibitors |
| 07/09/2003 | EP1324980A1 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 07/09/2003 | EP1324774A2 Use of a ppar delta activator for treating inflammatory conditions |
| 07/09/2003 | EP1324773A2 Use of a ppar delta activator in the treatment of diseases related to no inhibition or tnf inhibition |
| 07/09/2003 | EP1324771A2 Therapeutic antibodies |
| 07/09/2003 | EP1324766A2 Methods and compositions for the treatment of peripheral artery disease |
| 07/09/2003 | EP1324761A2 Uridine therapy for patients with elevated purine levels |
| 07/09/2003 | EP1324760A1 Creatine ester pronutrient compounds and formulations |
| 07/09/2003 | EP1324759A2 Nf-g(k)b inhibitors |
| 07/09/2003 | EP1324757A1 Protein prenyl transferase inhibitors in the treatment of neuroinflammatory disease |
| 07/09/2003 | EP1324755A1 Pharmaceutical solutions of modafinil compounds |
| 07/09/2003 | EP1324750A1 Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment |
| 07/09/2003 | EP1324652A2 Transgenic drosophila melanogaster expressing beta amyloid |
| 07/09/2003 | EP1224212B1 Tetrapeptide stimulating functional activity of neurones, pharmacological agent based thereon and method of use thereof |
| 07/09/2003 | EP1156798B1 Felbamate derived compounds |
| 07/09/2003 | EP1098871B1 alpha-AMINO ACID PHENYL ESTER DERIVATIVES |
| 07/09/2003 | EP1040096B1 Neuroprotective agents |
| 07/09/2003 | EP0994703B1 Composition comprising ketanserin and l-carnitine for the treatment of crps |
| 07/09/2003 | EP0988306B1 3-substituted 3,4 dihydro-thieno 2, 3-d]pyrimidine derivatives and production and use of the same |
| 07/09/2003 | EP0983262B1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists |
| 07/09/2003 | EP0912558B1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 07/09/2003 | EP0901483B1 Benzofurans and benzopyrans as chronobiological agents |
| 07/09/2003 | EP0894004B1 Method for enhancing functional recovery of motor coordination, speech or sensory perception after central nervous system ischemia or trauma |
| 07/09/2003 | EP0823906B1 Piperazino derivatives as neurokinin antagonists |
| 07/09/2003 | EP0612242B1 Use of the pure s(+) isomer of fluoxetine for the preparation of a medicament against migraine headache |
| 07/09/2003 | CN1429267A Neural progenitor cell populations |
| 07/09/2003 | CN1429226A Piperazine and piperidine compounds |
| 07/09/2003 | CN1429222A 激酶抑制剂 Kinase inhibitors |
| 07/09/2003 | CN1429221A 2-phenylpyran-4-one derivatives |
| 07/09/2003 | CN1429220A Crystalline base of citalopram |
| 07/09/2003 | CN1429219A Method for preparation of citalopram |
| 07/09/2003 | CN1429215A 三唑衍生物 Triazole derivatives |
| 07/09/2003 | CN1429210A Substituted thioacetamides |
| 07/09/2003 | CN1429206A 磺酰胺衍生物 Sulfonamide derivatives |
| 07/09/2003 | CN1429205A 磺酰胺衍生物 Sulfonamide derivatives |
| 07/09/2003 | CN1429200A Anthranyl amides and their use as medicaments |
| 07/09/2003 | CN1429113A Nutritional preparation comprising ribose and folic acid and medical use thereof |